A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of the study is to evaluate efficacy and safety of arbaclofen placarbil (XP19986) versus placebo as adjunctive therapy in subjects with troublesome GERD symptoms despite therapy with approved doses of a Proton Pump Inhibitor (PPI).
Epistemonikos ID: ee2b10b247dc2207fe8cea39bc8296aaf8f33c51
First added on: May 05, 2024